Skip to main content
. 2021 Oct 27;12:753224. doi: 10.3389/fpsyt.2021.753224

Figure 2.

Figure 2

Mendelian randomization analysis showing the effects of circulating leptin and soluble leptin receptor (sOB-R) levels on schizophrenia (SCZ) risk. (A) Mendelian randomization (MR) analyses of circulating leptin and SCZ. (B) MR analyses of sOB-R level and SCZ. (C) Forest plot for MR analyses of circulating leptin and SCZ. (D) Forest plot for MR analyses of sOB-R level and SCZ.